Scholars Central

Research articlePublished 31 Dec 2013

Synthesis and characterization of cephradine metal complexes as Alzheimer disease therapeutic agent: An in vitro kinetic study on acetyl cholinesterase and monoamine oxidase

Authors: Mamdouh S. Masouda, Alaa E. Ali, Doaa A. Ghareeb, Nessma M. Nasr

Journal of Chemical and Pharmaceutical Research

Volume 5 · Issue 12 · Pages 1325–1334

Ask about this article

Abstract

Select any words in the title or abstract, or press this and choose a sentence.

Cephradine metal complexes with Cr(III), Mn(II), Fe(III), Co(II), Cu(II), Zn(II), Cd(II), Hg(II) , mixed metals (Fe,Co) and (Fe,Cu) were synthesized and characterized by physicochemical and spectroscopic methods. Inhibitions of acetylcholinesterase, monoamine oxidase (MAO-B&A) by the prepared complexes were investigated. The brain AChE and MAO-A & B from Egyptian Mediterranean buffalo (Bas Buballus) was purified by ammonium sulphate precipitation and Sephadex G-25. The effect of the metallo cephradine on the activity of pure AChE and also (MAOB& A) were carried out in vitro by using standard colorimetric assays. The results revealed that AChE was inhibited by manganese and copper cephradine complexes in 1:1 and 3:1 (M:L) molar ratio, respectively as uncompetitive inhibitors with an enzyme-inhibitor dissociation constant (Ki value) of 21.75and 11.72 μmol/min/mg/protein and IC50 equals to 5.78 and 20 μM ,respectively. Also, the inhibition of MAO-B &A was tested for synthesized cephradine metal complexes. The mixed metal (Fe,Cu) cephradine complex is the best inhibitor for MAO-B as uncompetitive inhibitor. Enzyme-inhibitor dissociation constant (Ki value) and IC50 were 36.61μmol/min/mg/protein and 80.69 μM, respectively. From this study, it was found that Mn(II) in 1:1 and Cu(II) in 3:1 (M:L) molar ratio cephradine complexes act as potent inhibitors for AChE, while, the mixed metal (Fe,Cu) cephradine complex was a potent inhibitor for MAO-B. So, these three metallocephradine can be used for preventing neurodegenerative diseases such as Alzheimer΄s disease

Ask about this article

Answers come only from this article's title, abstract and keywords, each sentence pointing to where it comes from. Your question is sent to OpenAI to write the answer. Scholars Central does not store it.

Try:

More from this journal

The newest in Journal of Chemical and Pharmaceutical Research.

All its articles

Conferences in this field

Upcoming conferences in this field.

Follow

New articles from what you follow go into your email digest, once you agree to alert emails.

  • JournalJournal of Chemical and Pharmaceutical Research
  • SubjectPharmaceutical Sciences
  • SubjectChemistry
  • BylineArticles whose byline prints “Mamdouh S. Masouda”
  • BylineArticles whose byline prints “Alaa E. Ali”
  • BylineArticles whose byline prints “Doaa A. Ghareeb”
  • BylineArticles whose byline prints “Nessma M. Nasr”